US Adults Struggle With Long-Term Use Of Obesity Drugs Like Wegovy, Data Shows

benzinga.com/news/health-care/25/06/46102213/us-adults-struggle-with-long-term-use-of-obesity-drugs-like-wegovy-data-shows

Although glucagon-like peptide-1 (GLP-1) agonists have shown promising results in reducing weight and cardiovascular risks, new data reveals that many U.S. adults struggle to stay on long-term treatment.
While newer obesity-indicated GLP-1 therapies, such as semaglutide and tirzepatide,…

This story appeared on benzinga.com, 2025-06-25 18:50:47.
The Entire Business World on a Single Page. Free to Use →